ACOG Committee Opinion No. 651: Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Obstet Gynecol. 2015 Dec. 126 (6):e143-6. [QxMD MEDLINE Link].
Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018 Dec. 143 (3):393-408. [QxMD MEDLINE Link]. [Full Text].
Chumlea WC, Schubert CM, Roche AF, Kulin HE, Lee PA, Himes JH, et al. Age at menarche and racial comparisons in US girls. Pediatrics. 2003 Jan. 111 (1):110-3. [QxMD MEDLINE Link].
Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969 Jun. 44 (235):291-303. [QxMD MEDLINE Link]. [Full Text].
World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. World Health Organization Task Force on Adolescent Reproductive Health. J Adolesc Health Care. 1986 Jul. 7 (4):236-44. [QxMD MEDLINE Link].
Rosenfield RL. Clinical review: Adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013 Sep. 98 (9):3572-83. [QxMD MEDLINE Link]. [Full Text].
Vihko R, Apter D. Endocrine characteristics of adolescent menstrual cycles: impact of early menarche. J Steroid Biochem. 1984 Jan. 20 (1):231-6. [QxMD MEDLINE Link].
Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol. 1984 Aug 1. 149 (7):788-93. [QxMD MEDLINE Link].
Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: a study of 252 patients. Am J Obstet Gynecol. 1981 Jun 15. 140 (4):371-80. [QxMD MEDLINE Link].
Slap GB. Menstrual disorders in adolescence. Best Pract Res Clin Obstet Gynaecol. 2003 Feb. 17 (1):75-92. [QxMD MEDLINE Link].
Mashchak CA, Kletzky OA, Davajan V, Mishell DR Jr. Clinical and laboratory evaluation of patients with primary amenorrhea. Obstet Gynecol. 1981 Jun. 57 (6):715-21. [QxMD MEDLINE Link].
[Guideline] Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 Jul. 120 (1):197-206. [QxMD MEDLINE Link].
[Guideline] Committee on Practice Bulletins—Gynecology. Practice bulletin no. 136: management of abnormal uterine bleeding associated with ovulatory dysfunction. Obstet Gynecol. 2013 Jul. 122 (1):176-85. [QxMD MEDLINE Link].
Strickland JL, Wall JW. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am. 2003 Jun. 30 (2):321-35. [QxMD MEDLINE Link].
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012 Jan. 97 (1):28-38.e25. [QxMD MEDLINE Link].
Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999 Jun. 28 (2):341-59. [QxMD MEDLINE Link].
Carmina E, Oberfield SE, Lobo RA. The diagnosis of polycystic ovary syndrome in adolescents. Am J Obstet Gynecol. 2010 Sep. 203 (3):201.e1-5. [QxMD MEDLINE Link].
[Guideline] ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome. Obstet Gynecol. 2018 Jun. 131 (6):e157-e171. [QxMD MEDLINE Link].
[Guideline] Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1. Endocr Pract. 2015 Nov. 21 (11):1291-300. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2. Endocr Pract. 2015 Dec. 21 (12):1415-26. [QxMD MEDLINE Link]. [Full Text].
Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006 Feb. 91 (2):492-7. [QxMD MEDLINE Link].
Farhi DC, Nosanchuk J, Silverberg SG. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol. 1986 Dec. 68 (6):741-5. [QxMD MEDLINE Link].
Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol. 1990 Aug. 97 (8):734-9. [QxMD MEDLINE Link].
Claessens EA, Cowell CA. Acute adolescent menorrhagia. Am J Obstet Gynecol. 1981 Feb 1. 139 (3):277-80. [QxMD MEDLINE Link].
Minjarez DA, Bradshaw KD. Abnormal uterine bleeding in adolescents. Obstet Gynecol Clin North Am. 2000 Mar. 27 (1):63-78. [QxMD MEDLINE Link].
Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998 Feb 14. 351 (9101):485-9. [QxMD MEDLINE Link].
Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia. 1999 Sep. 5 (5):313-7. [QxMD MEDLINE Link].
Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993 Dec. 123 (6):893-8. [QxMD MEDLINE Link].
Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG. 2004 Jul. 111 (7):734-40. [QxMD MEDLINE Link].
Edlund M, Blombäck M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol. 1996 Dec. 53 (4):234-8. [QxMD MEDLINE Link].
[Guideline] National Heart, Lung, and Blood Institute. NIH Publication No. 08-5832. The diagnosis, evaluation, and management of von Willebrand disease. National Heart, Lung, and Blood Institute. Available at http://www.nhlbi.nih.gov/guidelines/vwd/vwd.pdf. December 2007; Accessed: May 8, 2023.
Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005 Nov. 84 (5):1345-51. [QxMD MEDLINE Link].
Committee on Adolescent Health Care., Committee on Gynecologic Practice. Committee Opinion No.580: von Willebrand disease in women. Obstet Gynecol. 2013 Dec. 122 (6):1368-73. [QxMD MEDLINE Link].
Jacobson L, Weström L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy. Am J Obstet Gynecol. 1969 Dec 1. 105 (7):1088-98. [QxMD MEDLINE Link].
Westhoff CL, Cooper S, Bishop IJ. Combined hormonal contraception. Jensen JT, Creinin MD, eds. Speroff and Darney's Clinical Guide to Contraception. 6th ed. Philadelphia: Wolters Kluwer; 2020. 219-300.
Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013 Aug 1. 8:CD003989. [QxMD MEDLINE Link].
Casey PM, Long ME, Marnach ML, Bury JE. Bleeding related to etonogestrel subdermal implant in a US population. Contraception. 2011 May. 83 (5):426-30. [QxMD MEDLINE Link].
Hubacher D, Chen PL, Park S. Side effects from the copper IUD: do they decrease over time?. Contraception. 2009 May. 79 (5):356-62. [QxMD MEDLINE Link]. [Full Text].
Janssen EB, Rijkers AC, Hoppenbrouwers K, Meuleman C, D'Hooghe TM. Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review. Hum Reprod Update. 2013 Sep-Oct. 19 (5):570-82. [QxMD MEDLINE Link].
Committee on Adolescent Health Care. ACOG Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, And Treatment. Obstet Gynecol. 2018 Jan. 131 (1):e35-e42. [QxMD MEDLINE Link]. [Full Text].
Krasna IH, Lee ML, Smilow P, Sciorra L, Eierman L. Risk of malignancy in bilateral streak gonads: the role of the Y chromosome. J Pediatr Surg. 1992 Nov. 27 (11):1376-80. [QxMD MEDLINE Link].
Committee opinion no. 605: primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014 Jul. 124 (1):193-7. [QxMD MEDLINE Link].
[Guideline] Gordon CM, Ackerman KE, Berga SL, Kaplan JR, Mastorakos G, Misra M, et al. Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017 May 1. 102 (5):1413-1439. [QxMD MEDLINE Link]. [Full Text].
Li M, Ruan X, Mueck AO. Management strategy of infertility in polycystic ovarian syndrome patients. Global Health J. 2022 Jun. 6 (2):70-4. [Full Text].
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7. 346 (6):393-403. [QxMD MEDLINE Link]. [Full Text].
Lethaby A, Duckitt K, Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013 Jan 31. 1:CD000400. [QxMD MEDLINE Link].
Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016 Jul 29. 65 (3):1-103. [QxMD MEDLINE Link].
Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-Lax E, DeSanctis Y, Jensen J. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels. Contraception. 2012 Nov. 86 (5):452-7. [QxMD MEDLINE Link].
Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J, et al. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013 Jan 10. 368 (2):128-37. [QxMD MEDLINE Link].
Matteson KA, Rahn DD, Wheeler TL 2nd, Casiano E, Siddiqui NY, Harvie HS, et al. Nonsurgical management of heavy menstrual bleeding: a systematic review. Obstet Gynecol. 2013 Mar. 121 (3):632-643. [QxMD MEDLINE Link].
ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstet Gynecol. 2018 May. 131 (5):e130-e139. [QxMD MEDLINE Link].
Menon S, COMMITTEE ON ADOLESCENCE. Long-Acting Reversible Contraception: Specific Issues for Adolescents. Pediatrics. 2020 Aug. 146 (2):[QxMD MEDLINE Link].
Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000. CD000249. [QxMD MEDLINE Link].
Hatcher RA, Nelson AL, Trussell J, Cwaik C, Cason P, Policar MS, et al. Contraceptive Technology. 21st ed. Atlanta, GA: Managing Conception LLC; 2019.
Abdel-Aleem H, d'Arcangues C, Vogelsong KM, Gaffield ML, Gülmezoglu AM. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev. 2013 Oct 21. 10:CD003449. [QxMD MEDLINE Link].
Harel Z. Dysmenorrhea in adolescents and young adults: etiology and management. J Pediatr Adolesc Gynecol. 2006 Dec. 19 (6):363-71. [QxMD MEDLINE Link].
Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2009 Apr 15. CD004753. [QxMD MEDLINE Link].
Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril. 2003 Sep. 80 (3):560-3. [QxMD MEDLINE Link].
Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A. Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain. Fertil Steril. 2006 Feb. 85 (2):314-25. [QxMD MEDLINE Link].
Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, et al. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. N Engl J Med. 2017 Jul 6. 377 (1):28-40. [QxMD MEDLINE Link].
Giudice LC, As-Sanie S, Arjona Ferreira JC, Becker CM, Abrao MS, Lessey BA, et al. Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet. 2022 Jun 18. 399 (10343):2267-2279. [QxMD MEDLINE Link].
Surrey ES. Gonadotropin-releasing hormone agonist and add-back therapy: what do the data show?. Curr Opin Obstet Gynecol. 2010 Aug. 22 (4):283-8. [QxMD MEDLINE Link].
[Guideline] Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC). U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep. 2013 Jun 21. 62 (RR-05):1-60. [QxMD MEDLINE Link]. [Full Text].
[Guideline] Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep. 2016 Jul 29. 65 (4):1-66. [QxMD MEDLINE Link]. [Full Text].